NSE Announcements on Aurobindo Pharm
Posted by :
MMB MessengerAurobindo Pharma Ltd has informed the Exchange regarding a press release dated November 09, 2009, titled "Aurobindo Pharma receives final approval for Cefotaxime for Injection USP". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Aurobindo Pharm
Posted by :
MMB MessengerAurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 09, 2009 titled "Aurobindo Pharma receives final approval for Cefotaxime for Injection USP"...
Aurobindo Pharma receives final USFDA approval
Posted by :
pms.swastika
Aurobindo Pharma receives final USFDA approval
Aurobindo Pharma receives final USFDA approval for its 2 new Injections.
Regards
Swastika PMS...
Aurobindo Pharma receives approval
Posted by :
PUNTERThe number of USFDA approvals is steadily increasing in its kitty. Aurobindo is definitely a multi-bagger. Buy and hold....
NSE Announcements on Aurobindo Pharm
Posted by :
MMB MessengerAurobindo Pharma Ltd has informed the Exchange regarding a press release dated November 06, 2009, titled "Aurobindo Pharma receives final approval for Lamotrigine Tablets from USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
Aurobindo Pharma receives approval
Posted by :
pms.swastika
Aurobindo Pharma receives approval
Aurobindo Pharma receives final approval for "Lamotrigine" tablets from USFDA.
Regards
Swastika PMS...
Auro near term target=900....
Posted by :
marketmanThe scrip is looking very strong.......
BSE Announcements on Aurobindo Pharm
Posted by :
MMB Messenger
Aurobindo Pharma Ltd has informed BSE that in terms of the issue of USD 60 Million Convertible Bonds due 2010, the Bonds are convertible at any time on or after September 20, 2005 up to August 01, 2010 by the holders of the Bonds into Equity Shares of Rs. 5/- each of the Company at a conversion price of Rs. 522.036 per share with a fixed rate of exchange on conversion at Rs. 43.3925 per US $ 1.
Accordingly, pursuant to the applications received for conversion from one of the Bondholders, the Committee of the Board of Directors of the Company at its meeting held on November 04, 2009 has considered the request and allotted 83,121 Equity Shares of Rs. 5/- each for cash at a premium of Rs. 517.036 by conversion of Bonds worth USD 1,000,000 in terms of the offer document to the FCCB holders.
Consequent to the aforesaid allotment the paid up capital of the Company has gone up from 53,765,268 Equity Shares of Rs. 5/- each to 53,848,389 Equity Shares of Rs. 5/- each....
NSE Announcements on Aurobindo Pharm
Posted by :
MMB MessengerAurobindo Pharma Ltd has informed the Exchange that "In terms of the issue, the Bonds are convertible at any time on or after 20th September 2005 up to 1st August 2010 by the holders of the Bonds into Equity Shares of Rs.5/- each of the Company at a conversion price of Rs.522.036 per share with a fixed rate of exchange on conversion at Rs.43.3925 per US $ 1. Accordingly, pursuant to the application received for conversion from one of the Bondholders, the Committee of the Board of Directors of the Company at its meeting held on 04.11.2009 has considered the request and allotted 83,121 Equity Shares of Rs.5/- each for cash at a premium of Rs.517.036 by conversion of Bonds worth USD 1,000,000 in terms of the offer document to the FCCB holders. Consequent to the aforesaid allotment the paid up capital of the Company has gone up from 53,765,268 Equity Shares of Rs.5/- each to 53,848,389 Equity Shares of Rs.5/- each"....
Auro near term target=900....
Posted by :
marketmanInvestors can hold the stockupto 900 till the next results.......
Auro near term target=900....
Posted by :
ambrishkapoor
Its consolidated net profit was at Rs 103.1 crore versus net loss of Rs 38.4 crore (moneycontrol and bse).
Excellent results can take it beyond 900 too. Lets c how it behaves on tuesday....
BSE Announcements on Aurobindo Pharm
Posted by :
MMB MessengerAurobindo Pharma Ltd has informed BSE regarding a Press Release dated October 30, 2009 titled "Aurobindo Pharma Q2 2009-10 Unaudited Results". ...
BSE Announcements on Aurobindo Pharm
Posted by :
MMB Messenger
Aurobindo Pharma Ltd has informed BSE that Dr. D. Rajagopala Reddy has been appointed as an Additional Director of the Company at the Boar Meeting held on October 30, 2009. He will function as a Non Executive and Independent Director of the Company.
Dr. S. Bimal Singh a Non Executive and Independent Director of the Company has resigned from the Board of the Company w.e.f. October 30, 2009.
...
BSE Announcements on Aurobindo Pharm
Posted by :
MMB MessengerAurobindo Pharma Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2009....
Auro near term target=900....
Posted by :
marketmanThe latest results are very good as expected.... full year eps could be 90 and at 10 pe multiple the scrip is said to be fairly valued at 900 for the near term.... there is nothing wrong in buying the scrip upto 900 during this year.......



Online


